MCMatthew T. Clark

Matthew T. Clark

*This is an algorithmically generated author record based on publicly available information.

Matthew T. Clark has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Development and evaluation of a prediction model for adult ICU hemorrhage using only continuous cardiorespiratory data

    by Andrew Barros, Brynne Sullivan, Matthew T Clark, Jiaxing Qiu, Jules Bergmann, Timothy Ruchti, Gilles Clermont

    Objective. Develop and evaluate whether a model trained to detect the physiological signature of hemorrhage in intensive care unit (ICU) patients generalizes to other cohorts. Approach. We collected cardiorespiratory monitoring data and packed red blood cell administration data from consecutive adult admissions in one development and three evaluation ICU cohorts. We defined hemorrhage as three or more transfusions within 24 h. We trained a penalized logistic regression model to predict hemorrhage within 8 h and externally evaluated the predictions. Main results. The evaluation ICU cohorts comprised more than 6M q15 min observations. The cross-validated area under the receiver operating characteristic (AUC) in the development cohort was 0.706 (141 event admissions, 95% confidence intervals (CIs): 0.656–0.757) and 0.712 (968 event admissions, 95% CI: 0.693–0.726) for 17 591 medical and surgical ICU patients in the combination of 3 evaluation cohorts. The calibration slope of the hemorrhage model was close to unity (1.041, 95%CI: 0.956–1.127). Predicted risk increased significantly in the 8 h preceding clinical recognition of bleeding. There was no evidence of model performance drifting over time. There was evidence for lower performance for patients over 75 (20% lower than patients 18–44), among patients at University of Pittsburgh (Pitt) (24% lower than MIMIC III), Black patients (11% lower than White patients), and females (12% lower than males). The shock index also had reduced performance at Pitt, for female patients, and for patients over 75, though not for Black patients. The hemorrhage score had a higher net benefit than the shock index. Significance. Patients in ICUs have an increased risk for bleeding due to their chronic and acute illness, and earlier bleeding identification leads to better outcomes. A risk model for hemorrhage based only on continuous cardiorespiratory data has clinically relevant predictive performance that generalizes across three cohorts with different monitoring devices and electronic health record systems.

  • Open Access

    Predictive Monitoring–Impact in Acute Care Cardiology Trial (PM-IMPACCT): Protocol for a Randomized Controlled Trial

    by Jessica Keim-Malpass, Sarah J Ratcliffe, Liza P Moorman, Matthew T Clark, Katy N Krahn, Oliver J Monfredi, Susan Hamil, Gholamreza Yousefvand, J Randall Moorman, Jamieson M Bourque

    Background: Patients in acute care wards who deteriorate and are emergently transferred to intensive care units (ICUs) have poor outcomes. Early identification of patients who are decompensating might allow for earlier clinical intervention and reduced morbidity and mortality. Advances in bedside continuous predictive analytics monitoring (ie, artificial intelligence [AI]–based risk prediction) have made complex data easily available to health care providers and have provided early warning of potentially catastrophic clinical events. We present a dynamic, visual, predictive analytics monitoring tool that integrates real-time bedside telemetric physiologic data into robust clinical models to estimate and communicate risk of imminent events. This tool, Continuous Monitoring of Event Trajectories (CoMET), has been shown in retrospective observational studies to predict clinical decompensation on the acute care ward. There is a need to more definitively study this advanced predictive analytics or AI monitoring system in a prospective, randomized controlled, clinical trial. Objective: The goal of this trial is to determine the impact of an AI-based visual risk analytic, CoMET, on improving patient outcomes related to clinical deterioration, response time to proactive clinical action, and costs to the health care system. Methods: We propose a cluster randomized controlled trial to test the impact of using the CoMET display in an acute care cardiology and cardiothoracic surgery hospital floor. The number of admissions to a room undergoing cluster randomization was estimated to be 10,424 over the 20-month study period. Cluster randomization based on bed number will occur every 2 months. The intervention cluster will have the CoMET score displayed (along with standard of care), while the usual care group will receive standard of care only. Results: The primary outcome will be hours free from events of clinical deterioration. Hours of acute clinical events are defined as time when one or more of the following occur: emergent ICU transfer, emergent surgery prior to ICU transfer, cardiac arrest prior to ICU transfer, emergent intubation, or death. The clinical trial began randomization in January 2021. Conclusions: Very few AI-based health analytics have been translated from algorithm to real-world use. This study will use robust, prospective, randomized controlled, clinical trial methodology to assess the effectiveness of an advanced AI predictive analytics monitoring system in incorporating real-time telemetric data for identifying clinical deterioration on acute care wards. This analysis will strengthen the ability of health care organizations to evolve as learning health systems, in which bioinformatics data are applied to improve patient outcomes by incorporating AI into knowledge tools that are successfully integrated into clinical practice by health care providers. Trial Registration: ClinicalTrials.gov NCT04359641; https://clinicaltrials.gov/ct2/show/NCT04359641 International Registered Report Identifier (IRRID): DERR1-10.2196/29631


  • Open Access

    Predictive Monitoring–Impact in Acute Care Cardiology Trial (PM-IMPACCT): Protocol for a Randomized Controlled Trial (Preprint)

    by Jessica Keim-Malpass, Sarah J Ratcliffe, Liza P Moorman, Matthew T Clark, Katy N Krahn, Oliver J Monfredi, Susan Hamil, Gholamreza Yousefvand, J Randall Moorman, Jamieson M Bourque

    BACKGROUND Patients in acute care wards who deteriorate and are emergently transferred to intensive care units (ICUs) have poor outcomes. Early identification of patients who are decompensating might allow for earlier clinical intervention and reduced morbidity and mortality. Advances in bedside continuous predictive analytics monitoring (ie, artificial intelligence [AI]–based risk prediction) have made complex data easily available to health care providers and have provided early warning of potentially catastrophic clinical events. We present a dynamic, visual, predictive analytics monitoring tool that integrates real-time bedside telemetric physiologic data into robust clinical models to estimate and communicate risk of imminent events. This tool, Continuous Monitoring of Event Trajectories (CoMET), has been shown in retrospective observational studies to predict clinical decompensation on the acute care ward. There is a need to more definitively study this advanced predictive analytics or AI monitoring system in a prospective, randomized controlled, clinical trial. OBJECTIVE The goal of this trial is to determine the impact of an AI-based visual risk analytic, CoMET, on improving patient outcomes related to clinical deterioration, response time to proactive clinical action, and costs to the health care system. METHODS We propose a cluster randomized controlled trial to test the impact of using the CoMET display in an acute care cardiology and cardiothoracic surgery hospital floor. The number of admissions to a room undergoing cluster randomization was estimated to be 10,424 over the 20-month study period. Cluster randomization based on bed number will occur every 2 months. The intervention cluster will have the CoMET score displayed (along with standard of care), while the usual care group will receive standard of care only. RESULTS The primary outcome will be hours free from events of clinical deterioration. Hours of acute clinical events are defined as time when one or more of the following occur: emergent ICU transfer, emergent surgery prior to ICU transfer, cardiac arrest prior to ICU transfer, emergent intubation, or death. The clinical trial began randomization in January 2021. CONCLUSIONS Very few AI-based health analytics have been translated from algorithm to real-world use. This study will use robust, prospective, randomized controlled, clinical trial methodology to assess the effectiveness of an advanced AI predictive analytics monitoring system in incorporating real-time telemetric data for identifying clinical deterioration on acute care wards. This analysis will strengthen the ability of health care organizations to evolve as learning health systems, in which bioinformatics data are applied to improve patient outcomes by incorporating AI into knowledge tools that are successfully integrated into clinical practice by health care providers. CLINICALTRIAL ClinicalTrials.gov NCT04359641; https://clinicaltrials.gov/ct2/show/NCT04359641 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/29631

  • Open Access

    Pathophysiologic Signatures of Bloodstream Infection in Critically Ill Adults

    by Alex N. Zimmet, Matthew T. Clark, Shrirang M. Mbbs Gadrey, Taison D. Md Bell, Amanda M. Zimmet, J. Randall Moorman, Christopher C. Moore

    Objectives: Bloodstream infection is associated with high mortality rates in critically ill patients but is difficult to identify clinically. This results in frequent blood culture testing, exposing patients to additional costs as well as the potential harms of unnecessary antibiotics. The purpose of this study was to assess whether the analysis of bedside physiologic monitoring data could accurately describe a pathophysiologic signature of bloodstream infection in patients admitted to the ICU. Design: Development of a statistical model using physiologic data from a retrospective observational cohort. Setting: University of Virginia Medical Center (Charlottesville, VA), a tertiary-care academic medical center. Patients: Critically ill patients consecutively admitted to either the medical or surgical/trauma ICUs with available physiologic monitoring data between February 2011 and June 2015. Interventions: None. Measurements and Main Results: We analyzed 9,954 ICU admissions with 144 patient-years of vital sign and electrocardiography waveform data, totaling 1.3 million hourly measurements. There were 15,577 blood culture instances, with 1,184 instances of bloodstream infection (8%). The multivariate pathophysiologic signature of bloodstream infection was characterized by abnormalities in 15 different physiologic features. The cross-validated area under the receiver operating characteristic curve was 0.78 (95% CI, 0.69–0.85). We also identified distinct signatures of Gram-negative and fungal bloodstream infections, but not Gram-positive bloodstream infection. Conclusions: Signatures of bloodstream infection can be identified in the routine physiologic monitoring data of critically ill adults. This may assist in identifying infected patients, maximizing diagnostic stewardship, and measuring the effect of new therapeutic modalities for sepsis.


  • Heart rate dynamics preceding hemorrhage in the intensive care unit

    by Travis J. Moss, Matthew T. Clark, Douglas E. Lake, J. Randall Moorman, J. Forrest Calland